SCHEMBL1120018

SCHEMBL1120018

O=C1C=c2ccccc2=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4437470 0.98
Hydrochloric Acid SCHEMBL8588250 0.98
SCHEMBL5841959 0.92
SCHEMBL28851876 0.81 SLC6A2 (0.30)
SCHEMBL28794969 0.74
SCHEMBL2231050 0.74
SCHEMBL5050110 0.74
SCHEMBL8402376 0.71 MEN1 (0.33)
SCHEMBL7900786 0.69 GABRA1 (0.33)
SCHEMBL29796872 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027123-A1 Compositions for Modulating Lipoxygenase and Methods of Using Same UNIV CALIFORNIA (US) 2026-01-29 US claimed
EP-4558508-A1 COMPOSITIONS FOR MODULATING LIPOXYGENASE AND METHODS OF USING SAME The Regents of the University of California (US) 2025-05-28 EP claimed
CN-119522227-A Macrocyclic compounds, pharmaceutical compositions and uses thereof 贝达药业股份有限公司 2025-02-25 CN claimed
WO-2024019959-A1 COMPOSITIONS FOR MODULATING LIPOXYGENASE AND METHODS OF USING SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-01-25 WO claimed
CN-106620899-A Graphene oxide-quinolone composite material 吴中区穹窿山师匠新材料技术咨询服务部 2017-05-10 CN claimed
CN-104086542-A Preparation method of pyrroloquinolinone compound UNIV CHONGQING 2014-10-08 CN claimed
CN-103951676-A Preparation method of thienoquinolinone compound UNIV CHONGQING 2014-07-30 CN claimed
CN-102015710-B Azatricyclic antibiotic compounds ACTELION PHARMACEUTICALS LTD 2013-04-24 CN claimed
WO-2008015516-A1 FUSED TRICYCLIC HETEROCYCLES FOR THE TREATMENT OF SCHIZOPHRENIA PFIZER PRODUCTS INC. (US) 2008-02-07 WO claimed
EP-1149080-A2 CRYSTALLINE FORM OF BENZOQUINOLINE-3-ONE DERIVATIVE AS INHIBITOR OF 5-ALPHA REDUCTASE ELI LILLY AND COMPANY (US) 2001-10-31 EP claimed
EP-1135373-A1 CRYSTALLINE FORM OF AN OCTAHYDRO-BENZO(F)QUINOLIN-3-ONE DERIVATIVE ELI LILLY AND COMPANY (US) 2001-09-26 EP claimed
WO-2000034246-A1 CRYSTALLINE FORM OF AN OCTAHYDRO-BENZO(F)QUINOLIN-3-ONE DERIVATIVE ELI LILLY AND COMPANY (US) 2000-06-15 WO claimed
WO-2000034245-A2 CRYSTALLINE FORM OF BENZOQUINOLINE-3-ONE DERIVATVE AS INHIBITOR OF 5-ALPHA REDUCTASE ELI LILLY AND COMPANY (US) 2000-06-15 WO claimed
WO-1999006401-A1 2-ARYL-2,5-DIHYDRO-PYRAZOLO[4,3-c]QUINOLIN-3-ONES AS GABA ALPHA 5 RECEPTOR INVERSE AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1999-02-11 WO claimed
WO-1998018757-A1 SYNTHESIS OF BENZO[F]QUINOLINONES ELI LILLY AND COMPANY (US) 1998-05-07 WO claimed
US-5696127-A Steroid receptor modulator compounds and methods LIGAND PHARMACEUTICALS INCORPORATED (US) 1997-12-09 US claimed
EP-0168309-B1 ISOXAZOLOQUINOLINONE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION, USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1988-03-09 EP claimed
EP-0168309-A1 Isoxazoloquinolinone derivatives, process and intermediates for their preparation, use as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1986-01-15 EP claimed
JP-5004986-A None JP disclosed
EP-0022078-B1 PYRAZOLO-QUINOLINES, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CIBA-GEIGY AG (CH) 1984-07-25 EP disclosed